DWP-700

N/A

Report date: 2025/01/26 18:46:57

Base Information

Drug NameDWP-700

Drug Alias NamehES-MSC (Daewoong Pharmaceutical)Human Embryonic Stem Cell-Derived Mesenchymal Stem Cell Therapy (DWP-700) (Daewoong)DWP-700

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionNeuroprotectants

TargetsUpdating

Therapy Area/IndicationsStroke

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDaewoong Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesDaewoong Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsStroke

Inactive IndicationsN/A

Other Information

ATC CodeN/A